These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia. Zavadska D, Bērziņa D, Drukaļska L, Pugacova N, Miklasevics E, Gardovska D. APMIS; 2010 May; 118(5):366-70. PubMed ID: 20477812 [Abstract] [Full Text] [Related]
4. Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program. Gracia M, Díaz C, Coronel P, Gimeno M, García-Rodas R, Rodríguez-Cerrato V, del Prado G, Huelves L, Ruiz V, Naves PF, Ponte MC, Granizo JJ, Soriano F. Diagn Microbiol Infect Dis; 2009 May; 64(1):52-6. PubMed ID: 19232860 [Abstract] [Full Text] [Related]
5. [Macrolide resistance phenotypes and genotypes in group G streptococci]. Açikgöz ZC, Göçer S, Almayanlar E. Mikrobiyol Bul; 2003 May; 37(2-3):117-24. PubMed ID: 14593892 [Abstract] [Full Text] [Related]
6. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002]. Senses Z, Baysallar M, Gür D, Doğanci L. Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258 [Abstract] [Full Text] [Related]
7. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries. Bandak SI, Turnak MR, Allen BS, Bolzon LD, Preston DA. Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986 [Abstract] [Full Text] [Related]
13. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France]. Mariani-Kurkdjian P, Doit C, Deforche D, Brahimi N, Francois M, Van den Abbeele T, Bingen E. Pathol Biol (Paris); 2004 Oct 02; 52(8):489-92. PubMed ID: 15465270 [Abstract] [Full Text] [Related]
14. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. Szczypa K, Sadowy E, Izdebski R, Hryniewicz W. J Antimicrob Chemother; 2004 Oct 02; 54(4):828-31. PubMed ID: 15329367 [Abstract] [Full Text] [Related]
15. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. Green MD, Beall B, Marcon MJ, Allen CH, Bradley JS, Dashefsky B, Gilsdorf JR, Schutze GE, Smith C, Walter EB, Martin JM, Edwards KM, Barbadora KA, Wald ER. J Antimicrob Chemother; 2006 Jun 02; 57(6):1240-3. PubMed ID: 16556634 [Abstract] [Full Text] [Related]
17. Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics. Sauermann R, Gattringer R, Graninger W, Buxbaum A, Georgopoulos A. J Antimicrob Chemother; 2003 Jan 02; 51(1):53-7. PubMed ID: 12493787 [Abstract] [Full Text] [Related]
20. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Bergman M, Huikko S, Pihlajamäki M, Laippala P, Palva E, Huovinen P, Seppälä H, Finnish Study Group for Antimicrobial Resistance (FiRe Network). Clin Infect Dis; 2004 May 01; 38(9):1251-6. PubMed ID: 15127336 [Abstract] [Full Text] [Related] Page: [Next] [New Search]